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Abstract:  Ubiquitination plays a critical role in many cellular processes. A growing 
number of viruses have evolved strategies to exploit the ubiquitin-proteasome system, 
including members of the Poxviridae family. Members of the poxvirus family have 
recently been shown to encode BTB/kelch and ankyrin/F-box proteins that interact with 
cullin-3 and cullin-1 based ubiquitin ligases, respectively. Multiple members of the 
poxvirus family also encode ubiquitin ligases with intrinsic activity. This review describes 
the numerous mechanisms that poxviruses employ to manipulate the ubiquitin-proteasome 
system.  
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1. Introduction 
Ubiquitin is a 76 amino acid protein that is best known for its role in protein degradation [1], 
however, the addition of ubiquitin can also serve roles not associated with protein degradation [2]. The 
post-translational addition of ubiquitin onto proteins occurs through a three step enzymatic cascade [3]. 
Ubiquitin is initially activated by one of two ubiquitin activating enzymes. Activated ubiquitin is 
subsequently transferred to a ubiquitin conjugating enzyme. In the final step, a ubiquitin ligase is 
responsible for the transfer of ubiquitin to the target protein. Proteins can be modified by 
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mono-ubiquitin or poly-ubiquitin [4]. Any one of seven lysine residues present in ubiquitin allows for 
the formation of ubiquitin chains. Lysine 48 and 63 are the most commonly used. Polyubiquitin chains 
formed on lysine 48 typically results in degradation through the 26S proteasome [1]. Conversely, 
polyubiquitin chains formed on lysine 63 tend to alter protein function [2]. More recently, linear 
ubiquitin has been associated with the regulation of nuclear factor B, and the ubiquitination of 
non-lysine residues has also been described [5,6]. 
The Poxviridae are a large family of viruses that infect a wide range of vertebrates and   
invertebrates [7]. The best known member of the family is variola virus, the causative agent of 
smallpox. Global eradication of smallpox was achieved in 1979 through a vaccination program 
initiated by the World Health Organization (WHO) [8]. Smallpox eradication used vaccinia virus, a 
close relative of variola virus, as a live vaccine [9]. By virus standards, poxvirus genomes are large 
ranging in size from 150–300 kbp; encoding upwards of 200 or more open reading frames [7]. Much 
interest in poxvirus biology stems from the observation that poxviruses employ a vast array of 
effective immune evasion strategies [10,11]. Additionally, the ease with which recombinant poxviruses 
are generated has made them attractive viruses for dissecting cellular signaling pathways [10]. 
Recently, protein ubiquitination has emerged as an important mechanism for the control of protein 
degradation and function, especially during virus infection [12–16]. In this review we focus on the 
strategies that poxviruses have developed to exploit the ubiquitin-proteasome system. 
2. Poxvirus Encoded Ubiquitin 
Ubiquitination is a post-translational modification that plays an essential role in many cellular 
processes [17]. Ubiquitin is a small 76 amino acid protein that is highly conserved in eukaryotes. In 
fact, only four amino acids differ between yeast, plants and mammalian ubiquitin sequences [18]. Two 
classes of ubiquitin-encoding genes are present in eukaryotic genomes. These including polyubiquitin 
genes that encode back-to-back ubiquitin sequences that are cleaved to produce ubiquitin monomers, 
and ubiquitin-carboxyl extension protein (CEP) fusion genes that encode a single ubiquitin sequence 
fused to a ribosomal sequence at the C-terminus that is incorporated into the ribosome [19]. Ubiquitin 
contains seven lysine residues that can be used to build ubiquitin chains [1,17,20]. Traditionally, 
ubiquitination is associated with protein degradation; however, current evidence indicates that 
ubiquitination has additional regulatory functions [1,17,20].  
Ubiquitin homologs have recently been identified in the genomes of poxviruses [21–23]. Two insect 
poxviruses: Melanoplus sanguinipes (MSEV) (Table 1) [21] and Amsacta moorei (AMEV) [22], as 
well as canarypox virus (CNPV), contain virus-encoded ubiquitin homologs [23]. Genomic analysis of 
MSEV, a poxvirus that infects locusts, identified the open reading frame MSEV144; encoding an 80 
amino acid protein that is 86% identical to human ubiquitin (Figure 1) [21]. However, the role that 
MSEV144 plays during viral infection has not been characterized. BLAST analysis also identified an 
additional poxvirus-encoded ubiquitin gene AMEV180, in AMEV, a poxvirus that infects moths. 
AMEV180 is 81 amino acids in length and 89% identical to human ubiquitin (Figure 1) [22]. 
Sequencing of canarypox, a poxvirus that infects song birds, identified another ubiquitin homolog, 
CNPV096, in canarypox virus (Figure 1) [23]. At 85 amino acids in length, CNPV096 contains all of 
the residues required for protein ubiquitination and is 98% identical to human ubiquitin [23]. Viruses 2010, 2                  
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Interestingly, fowlpox virus (FWPV), a close relative of canarypox virus, contains fragmented remains 
of a functional ubiquitin gene [24]. MSEV144, CNPV096, and AMEV180 are not part of the 
polyubiquitin gene class, and do not encode ribosomal peptides at the C-termini. In contrast to 
eukaryotes, which have multiple copies of ubiquitin-encoding genes, only one copy of each ubiquitin 
gene is present in the genomes of these viruses [21–23]. Virus-encoded ubiquitin genes have also been 
identified in Baculoviridae, a family of dsDNA viruses that infect insects [25]. Disruption of the 
ubiquitin gene in Autographa californica nuclear polyhedrosis virus (AcNPV) has no effect on virus 
viability, however, a decrease in virion budding and total infectious particles was observed [25]. 
Whether the ubiquitin-encoding genes in MSEV, AMEV, and CNPV are required for productive 
infection or virion budding remains to be determined. 
Figure 1. Poxvirus Encoded Ubiquitin. Amino acid sequences of MSEV144, AMEV180, 
CNPV096 and human ubiquitin were aligned using Clustal W [26,27]. Poxvirus amino 
acid sequences were obtained from  the Poxvirus Bioinformatics Resource Center [28]. 
Residues representing 100% conservation are shaded. 
 
 
Although most poxviruses do not encode their own ubiquitin genes, ubiquitin is associated with the 
virion. Proteomic analysis of vaccinia virus indicates that ubiquitin accounts for approximately 3% of 
total virion protein [29]. Additionally, a lipid-modified form of ubiquitin is associated with several 
viruses [25,30,31]. For example, baculovirus, African swine fever virus, herpes simplex virus and 
vaccinia virus incorporate lipid-modified ubiquitin in their envelopes [25,29–31]. Previous analysis of 
baculovirus AcNPV demonstrated that lipid-modified ubiquitin was present and that ubiquitin was host 
derived [25]. Scavenging ubiquitin from the host may represent another strategy used by poxviruses to 
increase the levels of ubiquitin available during infection. Alternatively, lipid-modified ubiquitin may 
exist in cell membranes for a cellular function, such as autophagosome formation, and the virus simply 
acquires it passively during envelope acquisition. Whether other poxviruses have lipid-modified 
ubiquitin incorporated into their envelopes has not been studied.  
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Table 1. Poxvirus encoded modulators of the ubiquitin-proteasome system. Poxviruses are 
known to encode a number of modulators of the ubiquitin-proteasome system. Included in 
this table are ubiquitin homologs encoded by poxviruses, as well as MARCH and p28 E3 
ubiquitin ligases, BTB/kelch and Ank/PRANC proteins that associate with cellular 
ubiquitin ligases, and poxvirus APC/cyclosome regulators. 
Involvement in 
Ubiquitination 
Genus Virus
a Gene/Protein 
Length, 
aa 
VBRC 
accession
b 
poxvirus-encoded 
ubiquitin homologs 
Avipoxvirus CNPV-VR111  96  85  VP0043569 
Betaentomopoxvirus AMEV-Moyer  180  81  VP0037620 
Unclassified 
Poxviridae 
MSEV-Tuc 144  80  VP0038302 
MARCH Poxviral 
E3 Ubiquitin Ligase 
Capripoxvirus GTPV-Pellor  8  162  VP0044818 
 LSDV-Nee  10  162  VP0040213 
 SPPV-A  8  162  VP0044517 
 Leporipoxvirus  MYXV-Lau  M153  206  VP0038581 
   RFV-Kas  gp153R  201  VP0038747 
 Suipoxvirus  SWPV-Neb  9  155  VP0040564 
 Yatapoxvirus  TANV-COD  5  156  VP0067544 
   YLDV-Davis  5  156  VP0040054 
   YMTV-Amano  4  156  VP0043053 
p28 Poxviral E3 
Ubiquitin Ligase 
Avipoxvirus CNPV-VR111 205  318  VP0043678 
   197  275  VP0043670 
 FWPV-Iowa  157  311  VP0037889 
     150  276  VP0037882 
 Capripoxvirus  LSDV-Nee  140  240  VP0040345 
   SPPV-A  136  240  VP0044645 
   GTPV-Pellor  127  240  VP0044947 
 Leporipoxvirus  MYXV-Lau  M143  234  VP0038572 
   RFV-Kas 
gp143R 
(N1R) 
234 VP0038740 
 Orthopoxvirus  CMLV-CMS  14R  242  VP0041112 
   CPXV-GRI  C7R  242  VP0042678 
   ECTV-Mos  12  241  VP0040932 
   MPXV-ZAR  D5R  242  VP0040369 
   VACV  IHD-W  p28  243 
c 
   VARV-BGD75maj  D6R
d 242  VP0038767 
   RPXV-Utr  8  242  VP0041370 
 Suipoxvirus  SWPV-Neb  138  246  VP0040694 
  Yatapoxvirus TANV-COD 143R  234  VP0067759 
   YMTV-Amano  143R  236  VP0043181 
 
Unclassified 
Poxviridae 
DPV-W1170_84 154  245  VP0045437 
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Table 1. Cont. 
Involvement in 
Ubiquitination 
Genus Virus
a Gene/Protein
Length, 
aa 
VBRC 
accessionb 
BTB/KELCH proteins 
associated with cullin-3-
based E3 ubiquitin ligase 
Capripoxvirus GTPV-Pellor  16  562  VP0044826 
      141  547  VP0044951 
      148  552  VP0044958 
      LSDV-NEE  19  569  VP0040222 
         144  547  VP0040349 
         151  550  VP0040356 
      SPPV-A  16  569  VP0044525 
         140  547  VP0044649 
         147  552  VP0044656 
   Leporipoxvirus  MYXV-Lau  M014L  517  VP0038442 
         M140R  553  VP0038569 
      RFV-Kas  gp013L  516  VP0038613 
         gp0140R  553  VP0038737 
   Orthopoxvirus  CMLV-CMS  21L  200  VP0041119 
         24L  512  VP0041122 
         38L  480  VP0041137 
         172R  564  VP0041317 
         186R  501  VP0041335 
      CPXV-GRI  D11L  521  VP0042668 
         C18L  512  VP0042689 
         G3L  485  VP0042703 
         A54R  564  VP0042838 
         B9R  501  VP0042849 
         B19R  557  VP0042686 
      ECTV-Mos  18  512  VP0040938 
         27  482  VP0040947 
         150  563  VP0041074 
         165  594  VP0041089 
      MPXV-ZAI  D12L  206  VP0040376 
         D19L  107  VP0040382 
         C9L  487  VP0040396 
      TATV-DAH68  24  150  VP0052942 
         43  480  VP0052961 
         181  219  VP0053099 
         196  209  VP0053114 
      VACV-COP  C2L  512  VP0039555 
         C5L  615  VP0039551 
         F3L  480  VP0039572 
         A55R  564  VP0039751 
      RPXV-Utr  15  204  VP0041377 
         18  512  VP0041380 
         31  480  VP0041393 
         162  564  VP0041526 Viruses 2010, 2                  
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Table 1. Cont. 
Involvement in 
Ubiquitination 
Genus Virus
a Gene/Protein
Length, 
aa 
VBRC 
accessionb 
   Suipoxvirus  SWPV-Neb  6  530  VP0040561 
         15  534  VP0040570 
         136  574  VP0040692 
   Yatapoxvirus  YLDV-Davis  19L  522  VP0040068 
         140R  570  VP0040192 
      YMTV-Amano  19L  524  VP0043062 
   Unclassified 
Poxviridae 
DPV-W1170_84 25  529  VP0045308 
         159  546  VP0045442 
ankyrin/PRANC proteins 
associated with cullin-1-
based E3 ubiquitin ligase  
Avipoxvirus FWPV-Iowa  12  331  VP0037744 
      14  437  VP0037746 
      18  700  VP0037750 
      22  578  VP0037754 
         26  436  VP0037758 
         31  341  VP0037763 
         162  603  VP0037894 
         218  461  VP0037952 
         219  434  VP0037953 
         222  747  VP0037956 
         227  361  VP0037961 
         228  525  VP0037962 
         231  256  VP0037965 
         232  482  VP0037966 
         233  512  VP0037967 
         234  428  VP0037968 
         240  410  VP0037974 
         243  262  VP0037977 
         244  668  VP0037978 
         246  592  VP0037980 
   Capripoxvirus  GTPV-Pellor  142  634  VP0044952 
         144  498  VP0044954 
         145  447  VP0044955 
         149  453  VP0044959 
      LSDV-Nee  145  634  VP0040350 
         147  498  VP0040352 
         148  447  VP0040353 
         152  489  VP0042090 
      SPPV-A  141  631  VP0044650 
         143  498  VP0044652 
         144  447  VP0044653 
         148  484  VP0044657 Viruses 2010, 2                  
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Table 1. Cont. 
Involvement in 
Ubiquitination 
Genus Virus
a Gene/Protein
Length, 
aa 
VBRC 
accessionb 
   Leporipoxvirus  MYXV-Lau  148R  675  VP0038576 
         149R  490  VP0038577 
         150R  494  VP0038578 
         005R (MT-5)  483  VP0038588 
   Orthopoxvirus  CMLV-CMS  3L  585  VP0041099 
         4L  672  VP0041101 
         177L  564  VP0041325 
         197R  783  VP0041349 
      CPXV-GRI  D3L  586  VP0042660 
         D4L  672  VP0042661 
         D8L (CP77)  661  VP0042665 
         C1L  437  VP0042672 
         C11L  614  VP0042682 
         B3R  558  VP0042843 
         B16R  574  VP0042856 
         B18R  795  VP0042858 
         K1R  581  VP0042863 
         I2R  672  VP0042868 
         I3R  586  VP0042869 
      ECTV-Mos  2  587  VP0040921 
         5  650  VP0040924 
         154  564  VP0041078 
         165  594  VP0041089 
      MPXV-ZAR  B5R  561  VP0040530 
         J1R  587  VP0040553 
         N4R  437  VP0040552 
         B17R  793  VP0040542 
      TATV-DAH68  220  640  VP0053138 
         187  558  VP0053105 
         18  661  VP0052936 
         6  627  VP0052924 
      VACV-Cop  B18R  574  VP0039778 
         C19L  259  VP0039532 
         B4R  558  VP0039761 
      RPXV-Utr  180  791  VP0041544 
         178  574  VP0041542 
         166  558  VP0041530 
      VARV-
BDG75maj 
B5R 558  VP0038933 
         G1R  585  VP0039159 
         B16R  574  VP0038944 
         B18R  787  VP0038946 Viruses 2010, 2                  
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Table 1. Cont. 
Involvement in 
Ubiquitination 
Genus Virus
a Gene/Protein
Length, 
aa 
VBRC 
accessionb 
   Parapoxvirus  ORFV-NZ2  8  516  VP0047660 
         123  525  VP0047777 
         126  497  VP0047780 
         128  500  VP0047782 
         129  520  VP0047783 
   Suipoxvirus  SWPV-Neb  141  635  VP0040697 
         142  485  VP0040698 
         143  430  VP0040699 
         144  493  VP0040700 
   Yatapoxvirus  YLDV-Davis  148R  476  VP0040200 
         147R  491  VP0040199 
         146R  473  VP0040198 
         11L  637  VP0040060 
      YMTV-Amano  11L  637  VP0043056 
         146R  356  VP0043184 
         147R  497  VP0043185 
         148R  483  VP0043186 
   Unclassified 
Poxviridae 
DPV-W1170_84 164  493  VP0045447 
         163  483  VP0045446 
         162  501  VP0045445 
         160  641  VP0045443 
         19  643  VP0045302 
poxvirus 
APC/cyclosome 
regulators 
Molluscipoxvirus MOCV-st1  026L  83  VP0038021 
Parapoxvirus BSPV-AR02  13  93  VP0043354 
ORFV-NZ2 14  93  VP0047667 
   Unclassified 
Poxvirdae 
CRV-ZWE 47  81 VP0066074 
   SPV  A11L  86  DQ377804
e 
a   Representative strains were chosen for each individual virus, and the viruses are abbreviated: Canarypox 
virus (CNPV), Fowlpox virus (FWPV), Goatpox virus (GTPV), Lumpy skin disease virus (LSDV), 
Sheepox virus (SPPV), Myxoma virus (MYXV), Rabbit fibroma virus (RFV), Molluscum contagiosum 
virus (MOCV), Camelpox virus (CMLV), Cowpox virus (CPXV), Ectromelia virus (ECTV), 
Monkeypox virus (MPXV), Taterapox virus (TATV), Vaccinia virus (VACV), Variola virus (VARV), 
Bovine papular stomatitis virus (BPSV), Orf virus (ORFV), Swinepox virus (SWPV), Tanapox virus 
(TANV), Yaba-like disease virus (YLDV), Yaba monkey tumor virus (YMTV), Amsacta moorei 
enomopoxvirus (AMEV), Melanoplus sanguinipes entomopoxvirus (MSEV), Mule deer poxvirus 
(DPV), Nile crocodile poxvirus (CRV), Squirrel poxvirus (SPV). 
b   VBRC accession numbers were obtained from the Poxvirus Bioinformatics Resource Center [28]. 
c   The complete VACV-IHD-W genome has not been published and an accession number is not available.  
d   D6R is also known as D4R, B5R or B6R, depending on the strain of VARV. 
e   The SPV genome is not available in the Poxvirus Bioinformatics Resource Center so the accession 
number from GENBANK was used. Viruses 2010, 2                  
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It seems unlikely that poxviruses would maintain an open reading frame that has no role during 
infection. To date, the function of the poxvirus encoded ubiquitin sequences has not been determined. 
Encoding additional pools of ubiquitin could be a mechanism used by entomopoxiruses and canarypox 
virus to increase efficiency of host cell modulation during infection. It is also possible that these 
viruses rely heavily on the ubiquitin-proteasome system. For example, it has been shown that members 
of the Orthopoxvirus family require a functional ubiquitin-proteasome  system for productive   
infection [32,33]. Alternatively, viral-encoded ubiquitin homologs may function to inhibit the ubiquitin 
proteasome system. The AcNPV-encoded ubiquitin functions as a chain terminator for K48 linked 
polyubiquitination, the linkage that targets proteins for degradation by the 26S proteasome [34]. As 
such, it is possible that poxvirus-encoded ubiquitin may also act as chain terminators to inhibit 
degradation of certain substrates. At present, the reason that only a few members of the poxvirus 
family encode ubiquitin homologs remains unclear. 
3. Poxvirus Encoded Ubiquitin Ligases 
Poxviruses encode two families of proteins with intrinsic ubiquitin ligase activity; a 
membrane-associated RING-CH (MARCH) ubiquitin ligase, and a really interesting new gene (RING) 
finger protein (Figure 2A and B) [35–38]. 
The MARCH family of proteins contains a modified RING domain (RING-CH) at the N-terminus 
as well as transmembrane domains that promote localization to membranes (Figure 2A) [39]. Cellular 
MARCH proteins play an important role in the down-regulation of membrane receptors including 
MHC class I, MHC class II, and CD4 [39]. In addition to a family of cellular MARCH proteins, 
MARCH ubiquitin ligases also exist in the genomes of herpesviruses and poxviruses (Table 1) [40]. 
Infection with myxoma virus (MYXV), a rabbit specific poxvirus that causes myxomatosis, results in 
reduction of cell surface MHC class I [35,41–43]. The loss of MHC class I upon myxoma virus 
infection was later associated with ubiquitin ligase activity of the myxoma virus encoded MARCH 
homolog, M153R [35,41]. In addition to the down-regulation of MHC class I, M153R also reduces cell 
surface expression of CD95, ALCAM (CD66) and CD4 [35,37,41]. The loss of CD4 by M153R has 
been well characterized. Upon infection, M153R ubiquitinates the cytoplasmic tail of CD4, leading to 
its internalization via endocytosis and subsequent lysosomal degradation [37]. Through the action of 
M153R, myxoma virus induced ubiquitination and degradation of cell surface immune molecules 
provides an important mechanism for dampening the immune response. 
p28 is a virus-encoded RING finger ubiquitin ligase that plays an important role in virulence 
(Figure 2B) [36,44,45]. p28 is highly conserved among pathogenic poxviruses and is expressed at both 
early and late times during virus infection (Table 1) [44,45]. The p28 ubiquitin ligase contains two 
functional domains; an N-terminal DNA binding domain, and a C-terminal RING domain (Figure 2B). 
The DNA binding domain of p28, referred to as KilA-N, remains largely uncharacterized [46]. This 
domain is found in a number of large DNA viruses as well as bacteria and bacteriophage [46]. The 
KilA-N domain plays an important role in the localization of p28 cytoplasmic viral   
factories [47,48]. In addition to being found in combination with a RING domain, the KilA-N domain 
is also found independently in some poxviruses. For example, eight KilA-N proteins are encoded in 
fowlpox virus (FWPV) and 23 KilA-N proteins are encoded in canarypox virus [23]. However, only Viruses 2010, 2                  
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two proteins in fowlpox virus and canarypox virus combine a KilA-N domain with a RING domain, 
likely encoding functional ubiquitin ligases [23,24,46].  
Figure 2. Poxvirus Encoded Ubiquitin Ligases. (A) Membrane associated RING-CH 
(MARCH) ubiquitin ligase. The MARCH ubiquitin ligase, M153R, encoded by myxoma 
virus contains two transmembrane domains and a C-terminal RING-CH domain. (B) p28, a 
RING Ubiquitin Ligase. p28 contains a C-terminal RING domain and an N-terminal 
KilA-N DNA binding domain. (C) BTB/Kelch ubiquitin ligases. BTB/Kelch proteins 
interact with cullin-3 through their BTB domain. Potential substrates are likely recruited 
through the kelch domain. (D) Ank/PRANC ubiquitin ligases. Cullin-1 interacts with 
Skp-1, which in turn interacts with Ank/PRANC proteins. The Ank domain potentially 
interacts with substrates recruiting them to the cullin-1 ubiquitin ligase. (E) Anaphase 
Promoting Complex (APC). It is hypothesized that PACR displaces APC11 subsequently 
disrupting APC function. 
 Viruses 2010, 2                  
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The C-terminal RING domain of p28 is responsible for ubiquitin ligase activity [36,38]. p28 
displays sequence homology to a family of cellular proteins termed Makorin (MKRN), however, this 
homology is restricted to the RING domain [49]. It has been suggested that the p28 family of poxvirus 
proteins were acquired through a fusion event of an existing KilA-N domain and a cellular   
MKRN [49]. Point mutations in the critical conserved residues of the RING domain disrupt 
ubiquitination [36,38]. Using in vitro ubiquitination assays, p28 homologs in ectromelia virus (ECTV), 
vaccinia virus (VV)-strain IHDW and variola virus (VARV) were shown to function as ubiquitin 
ligases [36,38]. The p28 ortholog in variola virus, D4R, functions in vitro with the ubiquitin 
conjugating enzymes, Ubc4 and UbcH5c [36]. Work in our laboratory has demonstrated that 
expression of p28 targets conjugated ubiquitin to viral factories [38]. K48 linked ubiquitin, which is 
associated with protein degradation, also co-localized at the virus factory with p28 [48]. Given that 
K48 linked ubiquitin is associated with proteasomal degradation it is likely that p28 plays a role in 
targeting substrates for degradation. Interestingly, variola virus D4R functions in vitro with Ubc13, the 
only known ubiquitin conjugating enzyme that promotes K63 linkages [36]. In contrast to K48 
linkages, K63 linkages are associated with non-proteolytic functions, suggesting that p28 may form 
K63 linkages during virus infection [36]. To date, no p28 substrates have been identified. However, 
p28 has been implicated in the inhibition of apoptosis [47,50]. It is therefore tempting to speculate that 
p28 may be targeting pro-apoptotic proteins for degradation. Since p28 localizes to viral factories, it is 
likely that potential substrates are located at the viral factory. Additionally, since p28 is expressed 
early during infection, prior to virus factory formation, p28 may also be responsible for ubiquitinating 
cytoplasmic substrates. 
In vivo studies have shown that p28 is a critical virulence factor during ectromelia virus (ECTV) 
infection [44]. In susceptible strains of mice, ectromelia virus devoid of p28 was extremely attenuated 
and all mice recovered; this is in sharp contrast to mice infected with wild-type virus, which succumb 
to infection [44]. Both wild type ectromelia virus and ectromelia virus devoid of p28 replicated equally 
well in all cell lines tested except for primary peritoneal macrophages [44,45]. Macrophages are 
thought to be critical for the transport of the virus, suggesting that the ubiquitin ligase activity of p28 
plays an important role in peritoneal marcrophages [45]. The role of p28 in virulence and its ability to 
function as a bona fide ubiquitin ligase suggests p28 is ubiquitinating substrates, however these 
substrates have yet to be identified. Identification of p28 substrates will undoubtedly provide important 
clues into the role of p28 in virus virulence. 
4. A Family of Poxvirus Encoded BTB/Kelch Proteins 
The BTB domain, also known as the POZ, Bric-a-Brac, Tramtrack, or Broad-complex, is a highly 
conserved protein-protein interaction motif that is involved in many cellular functions, including 
transcriptional and cytoskeletal regulation [51–53]. Recently, cellular BTB domain-containing proteins 
have been shown to function as substrate-specific adaptors of cullin-3 based ubiquitin ligase to target 
proteins for ubiquitination [54–57]. Unlike the well-characterized SCF (Skp1/Cul1/F-box) and ECS 
(elonginC/Cul2/SOCS) E3 complexes, in which Skp1/F-box or elonginC/SOCS combine to bridge 
substrates to cullins, BTB proteins fulfill this function through a single polypeptide containing the 
BTB domain as a linker to cullin-3 and a substrate-recruiting domain, such as kelch, MATH or Zinc Viruses 2010, 2                  
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Fingers (Figure 2C) [54–57]. Supporting this, the Skp1 and elonginC proteins display similar   
three-dimensional structure as the BTB domain [57–59]. The kelch domain consists of multiple 
repeated kelch motifs, and is thought to mediate protein-protein interactions (Figure 2C) [60]. 
A large group of BTB/kelch proteins have been identified in most members of the poxvirus family 
(Table 1) [61]. For example, vaccinia virus encodes three BTB/kelch proteins [62]; cowpox virus 
(CPXV) encodes six BTB/kelch proteins [63]; ectromelia virus strain Moscow (EVM) encodes four 
such proteins [64]; while monkeypox virus (MPXV) encodes only one BTB/kelch gene [65] (Table 1). 
Although the specific roles of the poxvirus BTB/kelch proteins are still unclear, it has been speculated 
that they may function as cullin-3 substrate-specific adaptors, similar to their cellular counterparts. In 
agreement with this idea, the BTB domains of ectromelia virus encoded BTB/kelch proteins EVM150 
and EVM167 are essential and sufficient for interaction with cullin-3 [66]. Consistently, EVM150 and 
EVM167 associate with conjugated ubiquitin and Roc1, the RING-finger protein required for an active 
cullin-3 ubiquitin ligase complex [66]. The other two ectromelia virus encoded BTB/kelch proteins, 
EVM018 and EVM027, also interact with cullin-3 [67]. Interestingly, EVM004, an ectromelia virus 
encoded protein containing only a BTB domain, does not interact with cullin-3, Roc1, or conjugated 
ubiquitin, suggesting that, unlike the other ectromelia virus encoded BTB/kelch proteins, EVM004 
may function independently of the ubiquitin-proteasome pathway [67]. The failure of EVM004 to 
interact with cullin-3 is currently unknown. Together, these findings suggest that poxviruses may 
employ BTB/kelch-cullin-3 ubiquitin ligase complex as another strategy to manipulate the cellular 
environment. Alternatively, the poxvirus BTB/kelch proteins may function by simply sequestering 
cullin-3 to inhibit the cullin-3-based cellular ubiquitin pathway. Given that poxviruses encode multiple 
BTB/kelch proteins with different kelch regions, it is probable that these viral BTB/kelch proteins 
function to specifically target different substrates to the cullin-3 ubiquitin ligase for ubiquitination.  
The importance of the poxvirus BTB/kelch proteins during virus infection has been studied. 
Vaccinia virus devoid of the BTB/kelch proteins C2L, F3L or A55R, the orthologs of EVM018, 
EVM027 and EVM150, respectively, displays an altered viral pathogenesis in the murine intradermal 
model [68–70]. Deletion of four BTB/kelch genes, D11L, C18L, G3L and A57R, from cowpox virus 
strain GRI-90 also results in altered host range and attenuated virulence [71]. Additionally, sheeppox 
virus (SPPV) BTB/kelch gene SPPV-019 has been shown to modulate cellular adhesion and affect 
virus virulence using a SPPV-019 knock-out virus model [72]. These observations suggest that 
BTB/kelch proteins function to manipulate the cellular host environment. To date, however, no 
definite substrates for the poxvirus BTB/kelch proteins have been identified, although several targets 
for cellular BTB/kelch proteins have been characterized. For example, NRF2, a critical nuclear 
transcription factor regulating oxidative stress, is degraded by KEAP1/cullin-3 ubiquitin ligase [73,74]. 
KEAP1 also functions as an IKK ubiquitin ligase [75]. Aurora B, a chromosomal passenger protein 
responsible for the proper progression of mitosis and cytokinesis, is targeted by KLHL21/Cul3 E3 for 
ubiquitination [76]. Interestingly, the vaccina virus encoded BTB/kelch protein, WR026 (COP-C2L), 
was recently shown through yeast-2-hybrid screening to interact with cellular crystallin alpha B 
(CRYAB), a small heat-shock protein [77]. Whether crystalline alpha B can be regulated by WR026 
for cullin-3-mediated ubiquitination needs to be investigated. Although the role of poxvirus BTB/kelch 
proteins is still undefined, many other viruses have evolved mechanisms to specifically recruit cellular 
proteins to cullin-based ubiquitin ligases [12,14]. Future identification of the substrates targeted by the Viruses 2010, 2                  
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poxvirus BTB/kelch proteins will provide new insight into the understanding of cellular anti-viral 
responses. 
5. Poxvirus Encoded Ankyrin/PRANC Proteins 
Ankyrin repeat proteins represent one of the largest families of proteins encoded by poxviruses. The 
ankyrin repeat consists of a 33 amino acid helix-loop-helix motif with a highly conserved amino acid 
sequence [78–80]. Ankyrin repeats were first identified in the cytoskeletal structural protein called 
ankyrin, which contains 24 ankyrin repeats [81]. Since its discovery, the ankyrin repeat has been 
characterized in a wide variety of cellular proteins, and generally mediates unique protein-protein 
interactions [78–80]. With the exception of molluscipoxviruses, all other poxvirus families encode a 
large repertoire of ankyrin proteins (Table 1). The largest family is encoded by canarypox virus and is 
comprised of 51 ankyrin repeat proteins, representing 21% of the canarypox virus genome [23,82]. 
Poxviral ankyrin repeat proteins are large proteins, ranging from 400–650 amino acids in length, 
containing between 5 to 10 ankyrin repeats located at their N-termini. Although the poxviral ankyrin 
repeat proteins contain no obvious structural domains at their C-termini, many of the proteins display a 
conserved sequence, which upon closer inspection was shown to resemble the F-box domain that 
functions in the recruitment of substrates to the cellular SCF (Skp-1, cullin, F-box) ubiquitin ligase 
complex [82–84]. The poxviral F-box-like domain was later named PRANC (pox protein repeat of 
ankyrin C-terminus) (pfam.janelia.org/family/PF09372). The SCF complex is a highly conserved 
ubiquitin ligase involved in regulation of the cell cycle, DNA repair, and innate immunity [17,85,86]. 
The complex consists of cullin-1, which serves as the molecular scaffold, Roc1, a RING finger 
ubiquitin ligase, Skp1, the linker protein, and one of over 70 known cellular F-box proteins which 
function in substrate recruitment (Figure 2D) [84–86]. Cellular F-box proteins consist of N-terminal 
F-box domains in conjunction with C-terminal protein binding domains such as WD40 repeats or 
leucine-rich repeats (LRR) [84–86]. The F-box domain consists of a highly conserved 50 amino acid 
sequence, folding into three alpha-helices, which function to bind the linker protein, Skp1, while 
WD40 repeats or LRRs function to bind substrates which are subsequently ubiquitinated through the 
ubiquitin ligase activity of Roc1 (Figure 2D) [59]. Substrates of the SCF ubiquitin ligase complex 
typically require a phosphorylation event prior to recognition by the substrate adaptor [83–86]. 
Until the recent identification of Ank/PRANC proteins in the parasitoid wasp, Nasonia, 
Ank/PRANC proteins were thought to be unique to poxviruses [87]. The poxvirus Ank/PRANC 
proteins differ from cellular F-box proteins in two important aspects. Firstly, the C-terminal location of 
the poxvirus F-box-like domain is unique to this set of proteins, and secondly, the poxvirus 
Ank/PRANC proteins contain truncated F-boxes (Figure 3) [82,88,89]. The cowpox virus encoded 
Ank/PRANC protein CP77 contains a PRANC domain that is only 13 amino acids in length and may 
represent the minimum requirement for interaction with Skp1 [90]. A related family of proteins, the 
suppressor of cytokine signaling (SOCS)-box family appear in conjunction with ankyrin repeats, and 
function as substrate adaptor molecules for the ECS ubiquitin ligases [91]. Since the SOCS-box and 
the F-box share sequence similarity it has been proposed that the poxviral ankyrin/F-box proteins were 
acquired as SOCS-box proteins that have evolved to regulate the cullin-1 based ligase [82,92].   
In addition to poxvirus encoded Ank/PRANC proteins, poxviruses also encode ankyrin only   Viruses 2010, 2                  
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proteins [82,93,94]. These ankyrin-only proteins do not contain PRANC domains, and have been 
proposed to have arisen from full length Ank/PRANC proteins [82]. 
Figure 3. Sequence alignment of ectromelia virus encoded Ank/PRANC proteins with 
cellular Skp2: AlignX was used to align the C-termini of EVM002, EVM005, EVM154, 
and EVM165 with the N-terminal F-box domain of Skp2, a cellular F-box protein [89]. 
Red dots indicate known contact points between Skp2 and Skp1 [59]. H1, H2, and H3 
represent alpha-helical secondary structures from Skp2. 
 
 
Ank/PRANC proteins have been identified in a wide range of poxviruses including vaccina virus, 
ectromelia virus, cowpox virus and Orf virus. Studies on myxoma virus identified the first interaction 
between a poxviral Ank/PRANC protein, M-T5, and the SCF complex [95]. MT-5, one of four 
Ank/PRANC proteins in myxoma virus, co-localizes with cullin-1 in the nucleus and regulates the cell 
cycle and interacts with Akt [95,96]. Myxoma virus encodes four Ank/ PRANC proteins (M-T5, 
M148, M149, M150) all of which play a role in myxoma virus virulence [97–99]. Interestingly, M150 
co-localized to the nucleus with the p65 subunit of nuclear factor kappa B (NF-B), suggesting that 
M150 is involved in inhibition of NF-B [99]. Each of the five Orf virus encoded Ank/PRANC 
proteins have been shown to associate with a functional SCF ubiquitin ligase complex, as 
demonstrated through in vitro ubiquitination assays [92]. In the case of the Orf virus proteins, the 
F-box-like domain was both necessary and sufficient to mediate the interaction with Skp1 and   
cullin-1 [92]. Similarly, the F-box domains of proteins from ectromelia virus, cowpox virus, and 
vaccinia virus are also essential for interaction with the SCF complex [89,90,100]. The cowpox virus 
encoded Ank/PRANC protein, CP77, functions as a host range protein that interacts with the NF-B 
transcription factor, p65, to inhibit the transcription of inflammatory cytokines [90,101]. Regulation of 
the NF-B signaling pathway by poxviral Ank/PRANC proteins appears to be a common trend. Using 
a yeast two-hybrid screen, the variola virus encoded G1R Ank/PRANC protein was shown to interact 
with the NF-B regulatory protein NFB1/p105 as well as Skp1 [102]. G1R, and its orthologs in 
cowpox virus, monkeypox virus, and ectromelia virus (CPXV006, MPXV003, EVM002), bind p105, 
and inhibit G1R degradation following TNF stimulus [102]. Additionally, a CPXV006 deletion virus 
displayed increased release of proinflammatory cytokines in culture, and was slightly attenuated in 
C57BL/6 mice infected [103].  
Although substrates have not been identified for the poxviral Ank/PRANC proteins, it has been 
hypothesized that the poxvirus Ank/PRANC proteins function as substrate adaptor proteins for the 
SCF complex. Although it is possible that the poxvirus Ank/PRANC proteins may simply bind and 
inhibit the SCF complex, this seems unlikely due to the large number of unique Ank/PRANC proteins Viruses 2010, 2                  
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encoded by poxviruses. For example, fowlpox virus encodes 20 Ank/PRANC proteins, each 
potentially targeting unique protein(s) for ubiquitination by the SCF complex (Table 1) [24]. 
Additionally, the ectromelia virus and Orf virus Ank/PRANC proteins have both been shown to 
associate with functional SCF complexes, suggesting that these proteins do not simply function as 
inhibitors [89,92]. The identification of substrates recruited to the SCF complex by poxviral 
Ank/PRANC proteins will be an essential step towards understanding this interesting family.  
6. Regulation of the APC/C by Poxviruses 
The anaphase promoting complex/cyclosome (APC/C) is the largest known cellular ubiquitin ligase 
complex, composed of at least 12 subunits (Figure 2E) [104]. Since its discovery almost 15 years ago 
its structure and regulation have proven to be increasingly complex. It is thought that the APC/C 
complex has evolved from an ancestral SCF-type ubiquitin ligase since the subunits APC2 and APC11 
resemble a cullin-family member and RING-type E3 ligase, respectively. APC2 functions as the 
molecular scaffold, and contains cullin homology and binds to the RING-finger protein APC11 [105]. 
APC11 has been shown to recruit ubiquitin-conjugating enzymes to the APC/C in order to catalyze the 
in vitro transfer of ubiquitin onto target substrates [106]. Substrates for the APC/C are recognized 
through the presence of D-box or KEN-box domains, which are recognized by a variety of APC/C 
components including Cdh1, Cdc20 and Doc1 [107,108]. The APC/C plays a major role in regulation 
of the cell cycle at several points, and most well known for its ability to degrade securin, a protein that 
regulates the separation of sister chromatids during anaphase [109]. 
A family of poxvirus RING-finger proteins was recently identified that contain sequence similarity 
with the RING domain of the APC/C subunit APC11 (Table 1) [110]. These APC11 homologs were 
identified in the parapoxviruses, molluscipoxviruses, as well as the crocodilepox and squirrelpox viruses. 
The poxvirus encoded APC11 homolog from Orf virus, a member of the parapoxvirus family, is the only 
homolog studied to date and has been named PACR (poxvirus APC/cyclosome regulator) [110]. PACR 
was shown to co-precipitate with APC/C subunits APC2, APC3 and APC4, and is shown to associate 
with the APC/C complex in a similar manner to APC11 [110]. However, upon sequence analysis, 
PACR and the other poxvirus orthologs contain mutations within the RING domain that inhibit the 
binding of E2 ubiquitin-conjugating enzymes to the complex, and therefore inhibit substrate 
ubiquitination [110]. It is thought that inhibition of APC/C may prompt cells into S-phase, a stage 
within the cell cycle where additional cellular factors may be present and contribute to virus 
replication. Additionally, two of the targets of the APC/C are cellular ribonucleotide reductase and 
thymidine kinase proteins, proteins that contribute to the free nucleotide pools required for DNA 
synthesis. Typically poxviruses encode their own thymidine kinase and ribonucleotide reductase genes, 
however, the viral thymidine kinase and ribonucleotide reductases genes are absent from Orf virus as 
well as other virus that encode homologs of PARC. In contrast, many viruses that encode their own 
thymidine kinase genes, lack PACR orthologs. It has been hypothesized that one of the main reasons 
for encoding APC/C inhibitors is to upregulate cellular thymidine kinase and ribonucleotide reductase 
genes to enhance free nucleotide pools in poxviruses that lack the ability to promote this themselves. 
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7. Role of the Ubiquitin-Proteasome System During Poxvirus Infection 
Poxviruses are renowned for creating an optimal environment for viral replication and   
propagation [7,11,111]. The ubiquitin-proteasome system, which plays a crucial role in protein 
degradation and cellular homoeostasis, is an attractive target for virus-encoded effector proteins. The 
ubiquitin-proteasome system is involved in regulating many important host pathways including 
antigen presentation, cell cycle progression, signal transduction, and DNA repair [1,17].   
Individual interactions between poxviral proteins and the ubiquitin-proteasome system have been   
characterized [15,16]. The study of the ubiquitin-proteasome system has been aided greatly by the use 
of chemical proteasome inhibitors. These inhibitors block the catalytic action of the proteasome by 
preventing the degradation of ubiquitinated proteins and reducing the amount of free ubiquitin 
available within the cell [112]. Proteasome inhibitors, including MG132, act to reversibly inhibit 
proteasome action while others, including MG115, lactacystin, and epoxomycin irreversibly inhibit the 
proteasome [113,114]. Notably, the bortezomib, sold under the trade name Velcade®, and licensed for 
the treatment of multiple myeloma, is a potent inhibitor of the proteasome [115]. The overall 
importance of a functioning ubiquitin-proteasome system during poxvirus infection has only recently 
been investigated [32,33].  
It has now been demonstrated that a functioning ubiquitin-proteasome system is vital to a successful 
infection by members of the Orthopoxvirus family [32,33]. In the presence of proteasome inhibitors, 
poxvirus replication is dramatically impaired [32,33]. Early poxviral gene expression is unaffected 
while intermediate and late gene expression is greatly reduced through the action of chemically distinct 
proteasome inhibitors. Viral factories, which normally appear as DNA rich areas in the cytoplasm of 
infected cells, are unable to form in the presence of proteasome inhibitors. In addition, it has been 
shown that plasmid replication, which can normally occur during poxvirus replication at viral   
factories [116], is blocked by the use of proteasome inhibitors [33]. The addition of proteasome 
inhibitors post-infection indicates that the block affects an early step during poxviral infection but does 
not affect the entry of poxvirus particles into the cell. Intriguingly, inhibition of the ubiquitin activating 
enzyme results in a similar phenotype during infection. Since overexpression of ubiquitin is unable to 
rescue late protein expression, DNA production and the generation of progeny virus, this data suggests 
that a functional ubiquitin-proteasome system as a whole is required for successful poxvirus   
infection [33]. Together, these observations indicate that viral DNA replication does not occur upon 
proteasome inhibition. The lack of viral DNA replication along with the pattern of gene expression 
seen upon treatement with proteasome inhibitors, points to viral uncoating and DNA replication as the 
likely candidates for the stage in the poxviral lifecycle actively blocked by proteasome   
inhibitors [32,33]. Further studies will undoubtedly lead to a greater understanding of the interactions 
between poxviruses and the ubiquitin-proteasome system and specifically the role of the proteasome 
during infection.  
The dramatic effect of proteasome inhibitors on poxvirus infection, suggests the proteasome may be 
an attractive target for the development of antivirals. Interestingly, proteasome inhibitors demonstrate 
an antiviral effect on a wide range of viruses including human immunodeficiency virus [117], influenza 
virus [118], vesicular stomatitis virus [118], coronavirus [119], human cytomegalovirus [120], 
respiratory syncytial virus [121], herpes simplex virus [122] and hepatitis B virus [123]. As such, Viruses 2010, 2                  
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proteasome inhibitors seem to demonstrate antiviral activity though distinct mechanisms among viral 
species. For example, proteasome inhibitors have been shown to impair entry and RNA synthesis 
during coronavirus infection [119], inhibit the entry of herpes simplex virus into the nucleus [122], and 
inhibit influenza and vesicular stomatitis virus replication [118]. However, in vivo studies recently 
conducted have produced mixed results. Treatment with bortezomib results in a decrease of circulating 
RNA in mice chronically infected with Hepatitis B [123], but proteasome inhibition enhances the 
disease and mortality in mouse hepatitis coronavirus [119], as well, increasing inflammation and 
mortality was observed in human respiratory syncytial virus [121]. A possible explanation for the 
seemingly conflicting results between the in vitro and in vivo experiments is through modulation of the 
immune system by proteasome inhibitors. It has been demonstrated that proteasome inhibitors affect 
antigen processing in vivo [124]. While proteasome inhibition may be antiviral, the effects on the 
immune system caused by proteasome inhibitors may increase susceptibility and mortality in some 
viral infections. Still, the proteasome remains a possible target for antiviral development against 
poxviruses and it would be interesting to determine whether proteasome inhibitors are able to inhibit 
poxvirus disease and mortality in vivo. 
8. Conclusions 
Since the first realization that poxviruses encode proteins with intrinsic ubiquitin ligase activity, the 
field has grown at a fast and exciting pace. It is clear from the current research that poxviruses encode 
multiple proteins that manipulate the ubiquitin-proteasome system. As discussed here, these strategies 
include the expression of poxvirus-encoded ubiquitin, ubiquitin ligases, BTB/kelch proteins, 
Ank/PRANC proteins, as well as inhibitors of the APC/C complex. The presence of multiple poxvirus-
encoded proteins suggests that poxviruses exploit the ubiquitin-proteasome in order to regulate cellular 
processes. In support of this, our recent observations indicate that upon infection with vaccinia virus 
the ubiquitin proteasome system is fully functional [125]. Within the field we have good track record 
of identifying and characterizing the poxvirus proteins involved in the ubiquitin-proteasome system. 
However, to date few substrates have been identified. Future studies are likely to focus on the 
identification of substrates for these viral ubiquitin ligases, as recent advancements in proteomics and 
mass spectrometry have paved the way to identifying ubiquitinated proteins [126–129]. Future studies 
will further our understanding of the intricate relationship between poxvirus replication and the 
ubiquitin-proteasome system.  
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